Chronic Active Antibody Mediated Rejection Targeting IL 6 to Improve Outcomes in Kidney Transplant

Chair, Stanley C. Jordan, MD, FASN, FAST, discusses antibody-mediated rejection in kidney transplant in this CME activity titled “Visualizing Progress in the Treatment of Chronic Active Antibody-Mediated Rejection: A Closer Look at the Clinical Potential of Targeting IL-6 to Improve Outcomes in the Kidney Transplant Setting.” For the full presentation, downloadable Practice Aids, and complete CME information, and to apply for credit, please visit us at PeerView.com/RBD865. CME credit will be available until May 10, 2024.